HEPATIC-ARTERY CHEMOTHERAPY FOR COLORECTAL LIVER METASTASES

被引:14
作者
MCCALL, JL [1 ]
JORGENSEN, JO [1 ]
MORRIS, DL [1 ]
机构
[1] UNIV NEW S WALES,ST GEORGE HOSP,DEPT SURG,KOGARAH,NSW 2217,AUSTRALIA
来源
AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY | 1995年 / 65卷 / 06期
关键词
COLORECTAL CANCER; HEPATIC ARTERY CHEMOTHERAPY; LIVER METASTASES;
D O I
10.1111/j.1445-2197.1995.tb01764.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Fifty per cent of patients with colorectal cancer develop hepatic metastases but only a minority are candidates for potentially curative surgical resection. Hepatic artery chemotherapy (HAC) has been used to treat patients with non-resectable metastases confined to the liver. Although response rates to HAC have been shown to be higher than response rates to systemic chemotherapy, the advantage in terms of survival has been debated. Furthermore, HAC requires surgical catheter placement which adds to the cost and morbidity of treatment. There have now been eight prospective randomized trials of HAC vs intravenous chemotherapy and/or supportive therapy. The present paper analyses the results of these trials with particular reference to survival. Surgical morbidity, treatment-related toxicity and cost are also discussed.
引用
收藏
页码:383 / 389
页数:7
相关论文
共 51 条
[1]  
ALLEGRA CJ, 1987, NATL CANCER I MONOGR, V5, P199
[2]   QUALITY-OF-LIFE AND SURVIVAL WITH CONTINUOUS HEPATIC-ARTERY FLOXURIDINE INFUSION FOR COLORECTAL LIVER METASTASES [J].
ALLENMERSH, TG ;
EARLAM, S ;
FORDY, C ;
ABRAMS, K ;
HOUGHTON, J .
LANCET, 1994, 344 (8932) :1255-1260
[3]   ANGIOGRAPHIC STUDY OF COLLATERAL CIRCULATION TO LIVER AFTER LIGATION OF HEPATIC ARTERY IN MAN [J].
BENGMARK, S ;
ROSENGREN, K .
AMERICAN JOURNAL OF SURGERY, 1970, 119 (06) :620-+
[4]   MAJOR HEPATIC RESECTION FOR COLORECTAL LIVER METASTASES [J].
BRADPIECE, HA ;
BENJAMIN, IS ;
HALEVY, A ;
BLUMGART, LH .
BRITISH JOURNAL OF SURGERY, 1987, 74 (04) :324-326
[5]  
BREEDIS C, 1954, AM J PATHOL, V30, P969
[6]  
CADY B, 1992, ARCH SURG-CHICAGO, V127, P561
[7]   A PROSPECTIVE RANDOMIZED TRIAL OF REGIONAL VERSUS SYSTEMIC CONTINUOUS 5-FLUORODEOXYURIDINE CHEMOTHERAPY IN THE TREATMENT OF COLORECTAL LIVER METASTASES [J].
CHANG, AE ;
SCHNEIDER, PD ;
SUGARBAKER, PH ;
SIMPSON, C ;
CULNANE, M ;
STEINBERG, SM .
ANNALS OF SURGERY, 1987, 206 (06) :685-693
[8]  
COHEN AM, 1986, CANCER, V57, P1115, DOI 10.1002/1097-0142(19860315)57:6<1115::AID-CNCR2820570609>3.0.CO
[9]  
2-P
[10]  
CURLEY SA, 1993, SURGERY, V114, P928